These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25320314)

  • 21. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
    Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
    J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.
    Lee SK; Harris J; Swanstrom R
    J Virol; 2009 Sep; 83(17):8536-43. PubMed ID: 19515760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient production of HIV-1 virus-like particles from a mammalian expression vector requires the N-terminal capsid domain.
    Jalaguier P; Turcotte K; Danylo A; Cantin R; Tremblay MJ
    PLoS One; 2011; 6(11):e28314. PubMed ID: 22140574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1.
    Milev MP; Brown CM; Mouland AJ
    Retrovirology; 2010 May; 7():41. PubMed ID: 20459747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cellular protein lyric interacts with HIV-1 Gag.
    Engeland CE; Oberwinkler H; Schümann M; Krause E; Müller GA; Kräusslich HG
    J Virol; 2011 Dec; 85(24):13322-32. PubMed ID: 21957284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
    Ono A; Orenstein JM; Freed EO
    J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 matrix-tRNA complex structure reveals basis for host control of Gag localization.
    Bou-Nader C; Muecksch F; Brown JB; Gordon JM; York A; Peng C; Ghirlando R; Summers MF; Bieniasz PD; Zhang J
    Cell Host Microbe; 2021 Sep; 29(9):1421-1436.e7. PubMed ID: 34384537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner.
    Hahn F; Schmalen A; Setz C; Friedrich M; Schlößer S; Kölle J; Spranger R; Rauch P; Fraedrich K; Reif T; Karius-Fischer J; Balasubramanyam A; Henklein P; Fossen T; Schubert U
    PLoS One; 2017; 12(4):e0174254. PubMed ID: 28388673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nucleocapsid domain of Gag is dispensable for actin incorporation into HIV-1 and for association of viral budding sites with cortical F-actin.
    Stauffer S; Rahman SA; de Marco A; Carlson LA; Glass B; Oberwinkler H; Herold N; Briggs JA; Müller B; Grünewald K; Kräusslich HG
    J Virol; 2014 Jul; 88(14):7893-903. PubMed ID: 24789788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles.
    Brandano L; Stevenson M
    J Virol; 2012 Feb; 86(4):2347-59. PubMed ID: 22156517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Determinants Directing HIV-1 Gag Assembly to Virus-Containing Compartments in Primary Macrophages.
    Inlora J; Chukkapalli V; Bedi S; Ono A
    J Virol; 2016 Oct; 90(19):8509-19. PubMed ID: 27440886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solution structure of calmodulin bound to the binding domain of the HIV-1 matrix protein.
    Vlach J; Samal AB; Saad JS
    J Biol Chem; 2014 Mar; 289(12):8697-705. PubMed ID: 24500712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.
    Alfadhli A; Staubus AO; Tedbury PR; Novikova M; Freed EO; Barklis E
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
    Ono A; Freed EO
    J Virol; 1999 May; 73(5):4136-44. PubMed ID: 10196310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNA.
    Ristic N; Chin MP
    Retrovirology; 2010 Sep; 7():73. PubMed ID: 20825656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HIV-1 matrix protein does not interact directly with the protein interactive domain of AP-3δ.
    Kyere SK; Mercredi PY; Dong X; Spearman P; Summers MF
    Virus Res; 2012 Nov; 169(2):411-4. PubMed ID: 22705971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Gag associates with specific uropod-directed microdomains in a manner dependent on its MA highly basic region.
    Llewellyn GN; Grover JR; Olety B; Ono A
    J Virol; 2013 Jun; 87(11):6441-54. PubMed ID: 23536680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
    Cimarelli A; Luban J
    J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
    J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.